Nurami Accepted to the MedTech Innovator Program

After a competitive process, Nurami is thrilled to have been chosen to participate in MedTech Innovator’s 2024 Accelerator Cohort. Nurami is one of 65 companies chosen, from 1,300 applicants.

For more information check out this MedTech Innovator announcement.